Latest news from SEQENS Group

All news

Events General PERSONAL CARE Press release Products & Technologies Protéus SD-CSR

SEQENS announces the appointement of a new CEO

France-based SEQENS, a leader in the development and production of active pharmaceutical ingredients, pharmaceutical intermediates, and specialty ingredients, announces that Pascal Villemagne has been named Chief Executive Officer, effective 1st April 2025. Pascal brings a wealth of experience to the role, having previously served as CEO of CARBOGEN AMCIS, a company specializing in the manufacture … Continued

Read more

Deviation management at SEQENS

Process safety management

Safety – The genesis: from laboratory to factory

Protéus by Seqens is now certified Gold Ecovadis

Safety is at the heart of our activities

Products & Technologies

MODENS® for styrene Butadiene copolymers, explore SEQENS’s expertise of Williamson Ether Synthesis

Digitalisation: La Madeleine launches the Qualit-e web platform

Seqens attended the annual conference of J.P Morgan 2021

Safety by design ® : a new approach to toxicological risk management

Decarbonization: SEQENS becomes a reference for the industry

Ruxandra Gref awarded with the SEQENS Prize of the French Académie des Sciences

Developing and producing critical molecules in France

1 … 5 6 7 8 9 … 11

Contact